ARTICLE | Company News
Avanir, OptiNose migraine marketing deal
July 3, 2013 1:01 AM UTC
OptiNose Inc. (Yardley, Pa.) granted Avanir Pharmaceuticals Inc. (NASDAQ:AVNR) exclusive North American rights to commercialize OptiNose's acute migraine product, OptiNose sumatriptan (AVP-825). OptiN...